Primary immunodeficiencies: molecular aspects and treatment.
Inserm U 132, Hôpital Necker-Enfants Malades, Paris.
A
A
Fischer
D000243:Adenosine Deaminase / Q000172:deficiency / Q000627:therapeutic use; D000818:Animals; D016913:Blood Component Transfusion; D016026:Bone Marrow Transplantation; D015316:Genetic Therapy; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000145:classification / Q000235:genetics* / Q000628:therapy; D051379:Mice; D016513:Mice, SCID; D011948:Receptors, Antigen, T-Cell / Q000235:genetics; D016511:Severe Combined Immunodeficiency / Q000235:genetics / Q000628:therapy
D011948:Receptors, Antigen, T-Cell; D000243:Adenosine Deaminase